Published in Int J Colorectal Dis on December 07, 2007
Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions. Int J Colorectal Dis (2009) 0.78
Recent advances in multidisciplinary approach for rectal cancer. Int J Clin Oncol (2015) 0.77
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med (2006) 12.50
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med (1997) 9.99
Mesorectal excision for rectal cancer. Lancet (1993) 7.33
Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol (2006) 7.05
Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet (2001) 6.38
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol (2005) 6.00
Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis (1997) 5.81
NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA (1990) 5.77
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst (2006) 4.14
Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br J Surg (1984) 3.82
Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg (2002) 3.32
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. J Clin Oncol (2005) 3.31
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol (2006) 3.24
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg (2006) 3.19
Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med (1985) 3.03
Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys (2006) 2.92
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol (2005) 2.77
Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol (2003) 2.69
Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol (1999) 2.67
Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet (2001) 2.64
A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum (2002) 2.53
Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys (2003) 2.38
Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol (2005) 2.33
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol (2004) 2.30
Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology (2007) 2.27
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys (2006) 2.26
Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer (1984) 2.26
No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol (2001) 2.20
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum (1998) 2.09
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol (2005) 2.07
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol (2004) 2.04
Towards fewer colostomies--the impact of circular stapling devices on the surgery of rectal cancer in a district hospital. Br J Surg (1980) 1.94
The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2003) 1.93
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol (2006) 1.89
Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg (1988) 1.87
Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol (2002) 1.78
Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer (1994) 1.77
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol (2001) 1.77
The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys (2002) 1.72
Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg (2005) 1.68
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol (2003) 1.67
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg (2002) 1.65
Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg (2005) 1.65
Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum (1994) 1.64
The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer (1995) 1.60
A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum (1997) 1.58
The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis (2003) 1.54
Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers. Int J Colorectal Dis (2003) 1.43
Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg (2001) 1.43
Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol (2003) 1.40
Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer (2006) 1.39
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer (2003) 1.36
Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum (2006) 1.35
'Close shave' in anterior resection. Br J Surg (1990) 1.33
Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys (2001) 1.30
New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. J Clin Oncol (2004) 1.27
Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: an overview. Dis Colon Rectum (1999) 1.23
Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer (1995) 1.23
Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol (2005) 1.21
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer (2004) 1.21
Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol (2005) 1.15
Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol (2001) 1.08
Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol (2007) 1.08
Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Eur J Surg Oncol (2001) 1.08
Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival. Cancer (1988) 1.05
Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol (1998) 1.01
Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol (2006) 1.01
Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer (1990) 1.00
Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis (2004) 0.99
Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg (2000) 0.99
The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence. Colorectal Dis (2006) 0.98
Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol (1995) 0.97
Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorectal Dis (2006) 0.96
The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol (1994) 0.95
Impact of surgeon's technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum (1999) 0.93
A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial. Dis Colon Rectum (1989) 0.93
The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol (2005) 0.92
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis (2004) 0.91
The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol (2003) 0.90
Development and validation of a colorectal functional outcome questionnaire. Int J Colorectal Dis (2004) 0.89
Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer (2006) 0.88
Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer? Int J Radiat Oncol Biol Phys (2006) 0.84
Distal rectal cancer: sphincter-sparing is also a challenge for the radiation oncologist. Radiother Oncol (2006) 0.84
Evaluation of preoperative and postoperative radiotherapy on long-term functional results of straight coloanal anastomosis. Dis Colon Rectum (2003) 0.83
Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum (2007) 0.82
Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design. Int J Radiat Oncol Biol Phys (2003) 0.82
Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg (2007) 0.81
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol (2009) 5.62
Choroidal metastasis in disseminated lung cancer: frequency and risk factors. Am J Ophthalmol (2002) 1.86
Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis. Eur Urol (2013) 1.59
Radiation-related damage to dentition. Lancet Oncol (2006) 1.49
Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol (2004) 1.48
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study. Strahlenther Onkol (2011) 1.45
Sustainability of skill courses for general and visceral surgery--evaluation of the long-term effect. Langenbecks Arch Surg (2009) 1.44
External beam radiotherapy of choroidal metastases--final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol (2002) 1.32
Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol (2005) 1.10
The German S3 guideline prostate cancer: aspects for the radiation oncologist. Strahlenther Onkol (2010) 1.09
High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol (2005) 1.05
Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study. Int J Radiat Oncol Biol Phys (2008) 0.96
Clostridium difficile infection of the small bowel--two case reports with a literature survey. Int J Colorectal Dis (2010) 0.91
Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning. Strahlenther Onkol (2006) 0.91
Hormone-refractory and metastatic prostate cancer - palliative radiotherapy. Front Radiat Ther Oncol (2008) 0.89
Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy : Long-term follow-up of a single-center survey. Strahlenther Onkol (2014) 0.87
Salvage radiotherapy after prostatectomy - what is the best time to treat? Radiother Oncol (2011) 0.85
Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines. Radiat Res (2008) 0.85
Long-term outcome after conservative and surgical treatment of acute sigmoid diverticulitis. Langenbecks Arch Surg (2011) 0.85
Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison. Strahlenther Onkol (2005) 0.83
Complications after end-to-end vs. side-to-side anastomosis in ileocecal Crohn's disease--early postoperative results from a randomized controlled multi-center trial (ISRCTN-45665492). Langenbecks Arch Surg (2013) 0.82
Diagnostic evaluation, surgical technique, and perioperative management after esophagectomy: consensus statement of the German Advanced Surgical Treatment Study Group. Langenbecks Arch Surg (2011) 0.81
Determination of the temperature-dependent electric conductivity of liver tissue ex vivo and in vivo: Importance for therapy planning for the radiofrequency ablation of liver tumours. Int J Hyperthermia (2010) 0.81
Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer. Strahlenther Onkol (2006) 0.81
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy. Strahlenther Onkol (2004) 0.80
High dose rate brachytherapy of localized prostate cancer. Eur Urol (2002) 0.80
Laparoscopic and open inguinal hernia repair with alloplastic material: do the subjective and objective parameters differ in the long-term course? Surg Laparosc Endosc Percutan Tech (2008) 0.80
Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease. Int J Colorectal Dis (2009) 0.79
Computed tomogram prior to prostatectomy. Advantage in defining planning target volumes for postoperative adjuvant radiotherapy in patients with stage C prostate cancer? Strahlenther Onkol (2002) 0.78
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin. BMC Med Inform Decis Mak (2013) 0.78
Pelvic sidewall involvement in recurrent rectal cancer. Int J Colorectal Dis (2003) 0.78
Measurable learning effects after a 1-week skills course in digestive surgery. Int J Colorectal Dis (2010) 0.78
Oligosymptomatic vs. symptomatic incisional hernias--who benefits from open repair? Langenbecks Arch Surg (2010) 0.78
[Five years of proton therapy of eye neoplasms at the Hahn-Meitner Institute, Berlin]. Z Med Phys (2004) 0.78
Salvage radiotherapy in patients with persisting prostate-specific antigen after radical prostatectomy for prostate cancer. Oncology (2003) 0.77
Treatment of rectal cancer. N Engl J Med (2006) 0.77
Dendritic cells from human mesenteric lymph nodes in inflammatory and non-inflammatory bowel diseases: subsets and function of plasmacytoid dendritic cells. Immunology (2013) 0.77
Bipolar radiofrequency ablation for nodular thyroid disease--ex vivo and in vivo evaluation of a dose-response relationship. J Surg Res (2009) 0.77
Laser-induced thermotherapy (LITT) elevates mRNA expression of connective tissue growth factor (CTGF) associated with reduced tumor growth of liver metastases compared to hepatic resection. Lasers Surg Med (2007) 0.77
Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck. Strahlenther Onkol (2007) 0.77
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results. World J Urol (2012) 0.77
Bipolar radiofrequency-induced thermofusion of intestinal anastomoses--feasibility of a new anastomosis technique in porcine and rat colon. Langenbecks Arch Surg (2011) 0.77
Pilot study of bipolar radiofrequency-induced anastomotic thermofusion-exploration of therapy parameters ex vivo. Int J Colorectal Dis (2009) 0.77
A new surgical trainer (BOPT) improves skill transfer for anastomotic techniques in gastrointestinal surgery into the operating room: a prospective randomized trial. World J Surg (2010) 0.76
Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model. Invest New Drugs (2011) 0.76
Microscopic findings in sigmoid diverticulitis--changes after conservative therapy. J Gastrointest Surg (2010) 0.76
Morphological alterations of the enteric nervous system in young male patients with rectal prolapse. Int J Colorectal Dis (2011) 0.76
Pelvic sites of recurrence in rectal cancer. Lancet (2002) 0.75
Postoperative radiotherapy for prostate cancer. Lancet (2005) 0.75
Treatment of localized lymphoma. N Engl J Med (2005) 0.75
In regard to Choo et al.: IJROBP 2002;52:674-680. Int J Radiat Oncol Biol Phys (2002) 0.75
Proton or photon irradiation for hemangiomas of the choroid? A retrospective comparison. Int J Radiat Oncol Biol Phys (2006) 0.75
Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning. Strahlenther Onkol (2006) 0.75
The value of PSA measurements at 30 Gy, 50 Gy and 60 Gy for dose limitation in patients with radiotherapy for PSA increase after radical prostatectomy. Strahlenther Onkol (2002) 0.75
Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol (2002) 0.75
Radiochemotherapy in unresectable pancreatic cancer. Front Radiat Ther Oncol (2004) 0.75
Is a diagnostic CT of the brain indicated in patients with choroidal metastases before radiotherapy? Strahlenther Onkol (2005) 0.75
Ex vivo evaluation of a bipolar application concept for radiofrequency ablation. Anticancer Res (2009) 0.75
Radiotherapy in biochemical recurrences after surgery for prostate cancer. Front Radiat Ther Oncol (2008) 0.75
[Treatment of keratitis superficialis chronica of the dog with strontium 90]. Strahlenther Onkol (2002) 0.75